Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $72.77
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Jul 5, 21 | Bernstein | downgrade | Market Perform | Underperform |
| Feb 24, 21 | Jefferies | upgrade | Underperform | Hold |
1075 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 59.20 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 64.17 | Oscillator | Neutral |
| Williams %R (14) | -23.31 | Oscillator | Neutral |
| MACD (12, 26, 9) | 1.22 (Hist 0.47) | Oscillator | Strong Buy |
| Average Directional Index (14) | 20.84 (+DI 49.0 / -DI 33.1) | Trend | Buy |
| EMA 20 | 69.78 | MA | Strong Buy |
| SMA 20 | 68.46 | MA | Strong Buy |
| EMA 50 | 68.81 | MA | Strong Buy |
| SMA 50 | 68.88 | MA | Strong Buy |
| SMA 200 | 71.47 | MA | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
Stock news · updated daily
A change in Reckitt's sales tactics led to 12 consecutive quarters of double-digit sales growth in the country.
These stocks have economic moats and look attractive today.
I rate Reckitt Benckiser a buy with a 12–24 month horizon and medium confidence, citing a 21% discount to peer multiples despite litigation overhang. Core Reckitt delivers high-margin, volume-led growth, with FY2025 organic growth of +5.2% and a 26.7% adjusted operating margin, supporting quality business status. Mead Johnson litigation risk remains the key discount driver; recent favorable legal outcomes improve sentiment but do not resolve federal MDL exposure.
Reckitt Benckiser Group LON: RKT reported accelerating sales growth in the second quarter of 2026, supported by innovation, emerging-market demand and a return to growth in North America, while maintaining its full-year outlook despite commodity and supply-chain volatility.
Reckitt Benckiser Group PLC (LSE:RKT) has launched a new £500 million share buyback after second-quarter sales accelerated across all regions and product categories. The maker of consumer products brands ranging from Dettol to Durex said like-for-like net revenue rose 4.7% in the second quarter, lifting first-half growth to 2.6%.
Dettol maker Reckitt beat second-quarter sales growth estimates and reaffirmed its annual forecast on Wednesday, as strong demand in China, India and other emerging markets helped offset weakness in Europe and disruption linked to the Iran war.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 1.88 | 1.34 | Miss -28.7% | $8.50B |
| Mar 5, 2026 | 2.54 | 2.48 | Miss -2.4% | $9.79B |
| Jul 24, 2025 | 2.32 | 2.01 | Miss -13.4% | $9.58B |
| Mar 6, 2025 | 2.01 | 2.45 | Beat 21.9% | $8.76B |
| Jul 24, 2024 | 2.05 | 2.12 | Beat 3.4% | $9.06B |
| Feb 28, 2024 | 1.94 | 1.37 | Miss -29.4% | $9.12B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| F-6EF | Aug 5, 2026 | 2026-08-05 12:37:26 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | RBGPF | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 12.4x | -136.2x · sector 38.2x | Discount |
| Forward P/E (FY26E) | 21.7x | EPS est. 3.35 | Elevated |
| Price / Book | 6.3x | 5.3x | Elevated |
| Price / Sales | 2.6x | 2.9x | In line |
| EV / EBITDA | 9.2x | 14.5x | Discount |
| Return on equity | 42.9% | — | Top tier |
| Gross margin | 59.5% | 59.5% | In line |
| Debt / Equity | 1.79 | 1.12 | Levered |
| Piotroski / Altman Z | 5/9 | Z 2.44 | Grey zone |
Discounted cash flow model